col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


26 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Journal of Biomedical Science
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―29 Characterization of binding affinity changes of SARS-CoV-2 omicron variant peptides to population-specific HLA Che-Mai Chang, Chang-Jiun Wu, Maxim Shkurnikov, Chin-Lin Guo, Wan-Chen Huang, Alexander Tonevitsky, Wei-Chiao Chang
2 [GO] 2024―Jul―13 A glimpse into viral warfare: decoding the intriguing role of highly pathogenic coronavirus proteins in apoptosis regulation Leyi Cheng, Yajuan Rui, Yanpu Wang, Shiqi Chen, Jiaming Su, Xiao-Fang Yu
3 [GO] 2024―Apr―18 Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19 Kun-Han Hsieh, Chiao-Hsuan Chao, Yi-Ling Cheng, Yen-Chung Lai, Yung-Chun Chuang, Jen-Ren Wang, et al. (+6)
4 [GO] 2023―Oct―12 Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission Chao-Fu Yang, Chun-Che Liao, Hung-Wei Hsu, Jian-Jong Liang, Chih-Shin Chang, Hui-Ying Ko, et al. (+5)
5 [GO] 2023―Aug―22 ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification Chia-Wen Wang, Huai-Chia Chuang, Tse-Hua Tan
6 [GO] 2023―Jul―31 Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2 Hsiao-Ling Chiang, Kang-Hao Liang, Ruei-Min Lu, Ting-Wen Kuo, Yi-Ling Lin, Han-Chung Wu
7 [GO] 2023―Jun―28 Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern Monika Kumari, Shih-Chieh Su, Kang-Hao Liang, Hsiu-Ting Lin, Yu-Feng Lu, Kai-Chi Chen, et al. (+2)
8 [GO] 2023―May―03 Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19 Jaung-Geng Lin, Guan-Jhong Huang, Yi-Chang Su
9 [GO] 2022―Dec―22 Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants Shih-Han Ko, Wan-Yu Chen, Shih-Chieh Su, Hsiu-Ting Lin, Feng-Yi Ke, Kang-Hao Liang, et al. (+4)
10 [GO] 2022―Nov―10 Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries Makoto Kurano, Daisuke Jubishi, Koh Okamoto, Hideki Hashimoto, Eri Sakai, Yoshifumi Morita, et al. (+8)
11 [GO] 2022―Oct―26 The pathogenesis of coronavirus-19 disease Alain C. Borczuk, Rhonda K. Yantiss
12 [GO] 2022―Oct―15 COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection Wei-Yu Chi, Yen-Der Li, Hsin-Che Huang, Timothy En Haw Chan, Sih-Yao Chow, Jun-Han Su, et al. (+3)
13 [GO] 2022―Sep―12 A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies Monika Kumari, Ruei-Min Lu, Mu-Chun Li, Jhih-Liang Huang, Fu-Fei Hsu, Shih-Han Ko, et al. (+11)
14 [GO] 2022―Jul―12 CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation Pei-Shan Sung, Shao-Ping Yang, Yu-Chun Peng, Cheng-Pu Sun, Mi-Hwa Tao, Shie-Liang Hsieh
15 [GO] 2022―Jul―07 A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants I-Jung Lee, Cheng-Pu Sun, Ping-Yi Wu, Yu-Hua Lan, I-Hsuan Wang, Wen-Chun Liu, et al. (+35)
16 [GO] 2022―Jul―03 Dengue and COVID-19: two sides of the same coin Gathsaurie Neelika Malavige, Chandima Jeewandara, Graham S. Ogg
17 [GO] 2022―Jun―09 Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy Chen-Yi Chiang, Mei-Yu Chen, Chia-Wei Hsu, Chia-Yeh Liu, Yu-Wen Tsai, Hung-Chun Liao, et al. (+9)
18 [GO] 2022―May―03 The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy Yiran Wang, Mandi Wu, Yichen Li, Ho Him Yuen, Ming-Liang He
19 [GO] 2022―Jan―04 Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection Yu-Chyi Hwang, Ruei-Min Lu, Shih-Chieh Su, Pao-Yin Chiang, Shih-Han Ko, Feng-Yi Ke, et al. (+3)
20 [GO] 2021―Nov―23 Antibody cocktail effective against variants of SARS-CoV-2 Kang-Hao Liang, Pao-Yin Chiang, Shih-Han Ko, Yu-Chi Chou, Ruei-Min Lu, Hsiu-Ting Lin, et al. (+5)
21 [GO] 2021―Jun―07 Identification of COVID-19 B-cell epitopes with phage-displayed peptide library Jing-You Guo, I-Ju Liu, Hsiu-Ting Lin, Mei-Jung Wang, Yu-Ling Chang, Shin-Chang Lin, et al. (+5)
22 [GO] 2021―Apr―30 A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions Ssu-Hsueh Tseng, Brandon Lam, Yu Jui Kung, John Lin, Li Liu, Ya Chea Tsai, et al. (+4)
23 [GO] 2021―Jan―12 Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications Ioannis P. Trougakos, Kimon Stamatelopoulos, Evangelos Terpos, Ourania E. Tsitsilonis, Evmorfia Aivalioti, Dimitrios Paraskevis, et al. (+3)
24 [GO] 2020―Dec―20 Coronavirus vaccine development: from SARS and MERS to COVID-19 Yen-Der Li, Wei-Yu Chi, Jun-Han Su, Louise Ferrall, Chien-Fu Hung, T.-C. Wu
25 [GO] 2020―Jun―07 The origin and underlying driving forces of the SARS-CoV-2 outbreak Shu-Miaw Chaw, Jui-Hung Tai, Shi-Lun Chen, Chia-Hung Hsieh, Sui-Yuan Chang, Shiou-Hwei Yeh, et al. (+3)
26 [GO] 2020―Jun―04 Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) Feng-Yee Chang, Hsiang-Cheng Chen, Pei-Jer Chen, Mei-Shang Ho, Shie-Liang Hsieh, Jung-Chung Lin, et al. (+2)
 [1] 

26 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec